Literature DB >> 18589871

Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.

Malgorzata Kamocka1, Morris Pollard, Mark Suckow, Wojciech P Mielicki, Elliot D Rosen.   

Abstract

Two common procoagulant activities associated with tumors are tissue factor and cancer procoagulant (CP), an activator of coagulation factor X. We have identified a convenient source of CP in transplanted Lobund-Wistar rat PA3 prostate tumors. CP activity was purified from 5 independent transplanted prostate tumors by column chromatography. The protein activated factor X in the absence of TF and factor VII. An antihuman CP antibody recognized rat CP in an ELISA and inactivated CP activity in a chromogenic assay. Lobund-Wistar prostate tumors may provide a convenient animal model useful in determining the role of CP in cancer development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589871      PMCID: PMC2704121     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  52 in total

1.  Cancer procoagulant and blood platelet activation.

Authors:  B Olas; B Wachowicz; W P Mielicki
Journal:  Cancer Lett       Date:  2001-08-28       Impact factor: 8.679

Review 2.  Cancer and the prothrombotic state.

Authors:  Gregory Y H Lip; Bernard S P Chin; Andrew D Blann
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

3.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.

Authors:  E G Fischer; M Riewald; H Y Huang; Y Miyagi; Y Kubota; B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.

Authors:  Z Hu; A Garen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 6.  Pathogenesis of thrombosis in patients with malignancy.

Authors:  A Falanga; M B Donati
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 7.  Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.

Authors:  J Chen; A Bierhaus; S Schiekofer; M Andrassy; B Chen; D M Stern; P P Nawroth
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

8.  Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats.

Authors:  Julie E Heinrich; Morris Pollard; William A Wolter; Zhong Liang; Hui Song; Elliot D Rosen; Mark A Suckow
Journal:  Cancer Immunol Immunother       Date:  2006-09-05       Impact factor: 6.968

Review 9.  Molecular basis for the relationship between thrombosis and cancer.

Authors:  F R Rickles; A Falanga
Journal:  Thromb Res       Date:  2001-06-15       Impact factor: 3.944

Review 10.  Factor VIIa/tissue factor-induced signaling: a link between clotting and disease.

Authors:  Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Vitam Horm       Date:  2002       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.